Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation

Bone Marrow Transplantation

Volumn 48, Issue 11, 2013, Pages 1478-1479

  Farnault, L ^a   Gertner Dardenne, J ^a   Gondois Rey, F ^a   Michel, G ^b   Chambost, H ^a   Hirsch, I ^a   Olive, D ^a  

^a INSERM   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN A; THYMOCYTE ANTIBODY; VIRUS DNA;

ADOLESCENT; ANTIGEN EXPRESSION; CASE REPORT; CD3+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNODEFICIENCY; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GAMMA DELTA T LYMPHOCYTE; GRAFT RECIPIENT; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; INTERFERON GAMMA RELEASE ASSAY; LETTER; LYMPHOCYTE COUNT; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTECTION; T CELL LEUKEMIA; VIRAL CLEARANCE; VIRUS LOAD;

ADOLESCENT; CORD BLOOD STEM CELL TRANSPLANTATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FETAL BLOOD; HERPESVIRUS 4, HUMAN; HUMANS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 84887237897     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.75     Document Type: Letter

References (0)